Expanding Access to Medication for the Treatment of Opioid Use Disorder

Year: 2021

Resolution Number: 22

Action Taken: Approved as Amended

Status: Complete

Author(s): May Chammaa, Tabitha Moses, and Brianna Sohl

Sponsor: Mara Darian

On behalf of: Medical Student Section

Committee: B (Legislation)

Resolved Section(s):
RESOLVED: That MSMS adopt policy in support of the requirement for obtaining a waiver to prescribe buprenorphine for the treatment of opioid use disorder; and be it furtherRESOLVED: That MSMS adopt policy in support of the removal of barriers to the use of medications for opioid use disorder; and be it furtherRESOLVED: That MSMS encourages all undergraduate medical institutions to incorporate into their curricula education on prescribing medications to treat opioid use disorders.

Fiscal Note: $1,000-$2,000

Resolution: View PDF for Expanding Access to Medication for the Treatment of Opioid Use Disorder

For More Information, Contact:

Stacey Hettiger , Director
Health Care Delivery
517-336-5732
shettiger@msms.org